News

Researchers Explore Application of Standard Definition of Systemic Lupus Erythematosus in a Swedish patient population

Christopher Sjöwall from the Rheumatology/AIR Department of Clinical and Experimental Medicine at Linköping in Sweden and colleagues, evaluated the performance of the Systemic Lupus International Collaborating Clinics (SLICC) criteria created in 2012 (SLIC-12) in a European population of patients with systemic lupus erythematosus (SLE). The study…

Kadmon Corporation’s Lupus Treatment Candidate Designated Top Priority

The Kadmon Corporation’s Phase 2 oral drug, KD025, a potent, bio-available and highly selective inhibitor of ROCK2 (Rho-associated coiled-coiled kinase 2) that can be taken orally was designed as one of its priority candidates to treat lupus through the LRxL-STAT Lupus Drug Repositioning Initiative. The selection of the drug was presented at the annual American College…

Anthera to Host Symposium on Systemic Lupus Erythematosus in January

Biopharmaceutical company Anthera Pharmaceuticals, Inc. is hosting a symposium on Systemic Lupus Erythematosus (SLE) designed for shareholders and investors, which is taking place on Wednesday, January 14, at 3:30 pm at the Mystic Hotel in San Francisco, CA. Anther is focused on the development and commercialization of medical options for the treatment of…

Lupus Research Institute Advocacy Hopes For Lupus Research and Education Support Gains In 2015 Congressional Appropriations

The New York and Chicago based non-profit Lupus Research Institute (LRI) Coalition, along with lupus patients nationwide are hopeful that the year-end Congressional Fiscal 2015 Consolidated and Further Continuing Appropriations Act will authorize support for several lupus research and professional education programs after the organization’s year-log advocacy. An…

Study Suggests Altering Gut Bacteria May Mitigate Lupus Symptoms

According to research recently published in the American Society for Microbiology’s journal Applied and Environmental Microbiology, Lactobacillus — a probiotic (beneficial bacteria) species commonly found in yogurt cultures — has been discovered to correlate in the gut of laboratory mouse models, with symptom mitigation in the autoimmune disorder systemic…